Background illustration for clinical trials search

Paid Clinical Trials Los Angeles

Discover 3,580 paid clinical trials in Los Angeles, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

GALLANT: Metronomic Gemcitabine, Doxorubicin, Docetaxel and Nivolumab for Advanced Sarcoma

for
Sarcoma
Location: Santa Monica CA
Sponsor: Sarcoma Oncology Research Center, LLC

Sex: All

Age: 18+

Code: NCT04535713

Phase 2, Recruiting

Ruxolitinib With De-Intensified HLH-94 for the Treatment of Hemophagocytic Lymphohistiocytosis (HLH)

for
Hemophagocytic Lymphohistiocytoses
Location: Irvine CA, San Diego CA, San Francisco CA,
Sponsor: Jerry Lee, MD, MSc, MPhil

Sex: All

Age: 18+

Code: NCT06160791

Phase 2, Recruiting

A Study to Test the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures

for
Stereotypical Prolonged Seizures
Location: Downey CA, Long Beach CA, La Jolla CA, Sacramento CA,
Sponsor: UCB Biopharma SRL

Sex: All

Age: 12+

Code: NCT05077904

Phase 3, Recruiting

A Study Evaluating the Efficacy and Safety of Xywav Expanded Dosing vs Placebo in Participants With Narcolepsy or IH

for
Narcolepsy, Idiopathic Hypersomnia
Location: Los Angeles CA, Long Beach CA, Irvine CA,
Sponsor: Jazz Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT07625280

Phase 3, Recruiting

DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy

for
Extrapulmonary Neuroendocrine Cancer (epNEC)
Location: Duarte CA, St Louis MO, Nashville TN, Atlanta GA,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT07544654

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

L19IL2/L19TNF in Patients With Cutaneous Squamous Cell Carcinoma

for
Locally Advanced Cutaneous Squamous Cell Carcinoma
Location: Orange CA, Houston TX, Atlanta GA, Durham NC, Boston MA
Sponsor: Philogen S.p.A.

Sex: All

Age: 18+

Code: NCT07228442

Phase 2, Recruiting

A Study of Pitolisant in Patients With Prader-Willi Syndrome

for
Prader-Willi Syndrome
Location: Los Angeles CA, San Diego CA, Sacramento CA, Aurora CO,
Sponsor: Harmony Biosciences Management, Inc.

Sex: All

Age: 6+

Code: NCT06366464

Phase 3, Recruiting

Study of Cemiplimab Plus Ziv-Aflibercept for Subjects With Metastatic Uveal Melanoma

for
Metastatic Uveal Melanoma
Location: Los Angeles CA, Chicago IL, Tampa FL, New Hyde Park NY
Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Sex: All

Age: 18+

Code: NCT06121180

Phase 2, Recruiting

First In Human Study of CX-801 in Advanced Solid Tumors

for
Solid Tumor, Adult
Location: Los Angeles CA, Englewood CO, Fort Worth TX,
Sponsor: CytomX Therapeutics

Sex: All

Age: 18+

Code: NCT06462794

Phase 1, Recruiting

A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer

for
Unresectable Melanoma, Metastatic Melanoma,
Location: Los Angeles CA, Westwood KS, Louisville KY,
Sponsor: Iovance Biotherapeutics, Inc.

Sex: All

Age: 18 - 70

Code: NCT05361174

Phase 1, Phase 2, Recruiting

Study to Assess the Efficacy and Safety of Rina-S With or Without Bevacizumab Compared to Investigator's Choice of Platinum-based Chemotherapy With or Without Bevacizumab as Second-line Treatment in Participants With Recurrent Platinum-sensitive Ovarian Cancer

for
Platinum-Sensitive Ovarian Cancer, Ovarian Cancer
Location: Duarte CA, Tigard OR, Waukesha WI, Morgantown WV,
Sponsor: Genmab

Sex: Female

Age: 18+

Code: NCT07564141

Phase 3, Recruiting

A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies

for
Solid Tumor, Adult, Refractory Cancer,
Location: Los Angeles CA, Portland OR, Houston TX,
Sponsor: GV20 Therapeutics

Sex: All

Age: 18+

Code: NCT05669430

Phase 1, Phase 2, Recruiting

Study of TBX-3400 in Patients With Stage III and IV Melanoma Resistant or Refractory to Immune Checkpoint Inhibitors

for
Stage III Melanoma, Stage IV Melanoma
Location: Los Angeles CA, Denver CO
Sponsor: Taiga Biotechnologies, Inc.

Sex: All

Age: 18+

Code: NCT03385486

Phase 1, Recruiting

Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors

for
Melanoma Stage IV, Solid Tumor
Location: Los Angeles CA, Fullerton CA, Bakersfield CA,
Sponsor: Georgiamune Inc

Sex: All

Age: 18+

Code: NCT06425926

Phase 1, Phase 2, Recruiting

Transcatheter Tricuspid Valve Replacement With the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in Severe Tricuspid Regurgitation

for
Severe Tricuspid Regurgitation
Location: Thousand Oaks CA, Phoenix AZ, Minneapolis MN,
Sponsor: Medtronic Cardiovascular

Sex: All

Age: 18+

Code: NCT07321899

Recruiting

Loncastuximab Tesirine and Mosunetuzumab for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma

for
Recurrent Diffuse Large B-Cell Lymphoma,
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT05672251

Phase 2, Recruiting

SNV4818 in Participants With Advanced Solid Tumors

for
Advanced Solid Tumors
Location: Los Angeles CA, Houston TX, Nashville TN, Toronto,
Sponsor: Pikavation Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06736704

Phase 1, Phase 2, Recruiting

BBO-11818 in Adult Subjects With KRAS Mutant Cancer

for
Non-Small Cell Lung Cancer, NSCLC,
Location: Los Angeles CA, San Diego CA, San Francisco CA,
Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)

Sex: All

Age: 18+

Code: NCT06917079

Phase 1, Recruiting

Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets

for
Idiopathic Pulmonary Fibrosis
Location: Newport Beach CA, Palm Springs CA, Reno NV, Redding CA,
Sponsor: Trevi Therapeutics

Sex: All

Age: 40+

Code: NCT07671911

Phase 3, Recruiting

A Study to Learn About the Study Medicine Called Rimegepant in Adults When Used for the Prevention of Chronic Migraine

for
Preventive Treatment of Migraine
Location: Los Angeles CA, Canoga Park CA, Fresno CA,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07729462

Phase 3, Recruiting

With a vast healthcare network and top-tier medical research centers, Los Angeles is a key hub for a wide range of clinical trials. Renowned institutions such as UCLA Health, Cedars-Sinai Medical Center, and the Keck School of Medicine at USC lead pioneering research across various fields, including cancer, cardiovascular health, and neuroscience.

Many Los Angeles medical centers are at the forefront of innovative studies, positioning the city as a critical location for advancing medical research and improving patient care outcomes.

Why choose Los Angeles for clinical trials?

Los Angeles offers distinct advantages for individuals participating in clinical trials. The city’s diverse population provides a wide range of participants, enhancing the accuracy and applicability of research findings across different demographics.

Known for its forward-thinking research environment, Los Angeles is home to leading institutions that drive cutting-edge studies in a variety of medical fields. By choosing to participate in a clinical trial in Los Angeles, individuals contribute to groundbreaking medical research while benefiting from the city's well-established clinical research infrastructure and access to world-class healthcare professionals.

Common conditions studied in Los Angeles

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Los Angeles